BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23484202)

  • 1. Prognostic role of tumor-associated proteases in colorectal cancer.
    Kushlinskii NE; Gershtein ES; Korotkova EA; Prorokov VV
    Bull Exp Biol Med; 2013 Jan; 154(3):365-9. PubMed ID: 23484202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor associated proteases -- prognostic markers of colorectal cancer.
    Gershtein ES; Korotkova EA; Prorokov VV; Kushlinskii NE
    Klin Lab Diagn; 2013 Oct; (10):43-7, 5-10. PubMed ID: 24640092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
    Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
    Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
    Kushlinskii NE; Gershtein ES; Alferov AA; Bezhanova SD; Mushtenko VV; Pushkar DY; Matveev VB; Stilidi IS
    Bull Exp Biol Med; 2020 Mar; 168(5):673-676. PubMed ID: 32248449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
    Frenoux C; Rebischung C; Quesada JL; Mendosa C; Letoublon C; Trocmé C
    Bull Cancer; 2018 Oct; 105(10):884-895. PubMed ID: 30243479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patient].
    Gershteĭn ES; Kushlinskiĭ NE
    Vestn Ross Akad Med Nauk; 2013; (5):16-27. PubMed ID: 24000664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
    Holten-Andersen MN; Stephens RW; Nielsen HJ; Murphy G; Christensen IJ; Stetler-Stevenson W; Brünner N
    Clin Cancer Res; 2000 Nov; 6(11):4292-9. PubMed ID: 11106246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
    BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients.
    Waas ET; Hendriks T; Lomme RM; Wobbes T
    Dis Colon Rectum; 2005 Apr; 48(4):700-10. PubMed ID: 15906450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
    Gunes M; Kemik AS; Pirincci N; Gecit I; Taken K; Yuksel MB; Kaba M; Eryilmaz R
    Asian Pac J Cancer Prev; 2013; 14(2):873-6. PubMed ID: 23621254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
    Fuksiewicz M; Kotowicz B; Rutkowski A; Kowalska M
    Tumour Biol; 2015 May; 36(5):3629-35. PubMed ID: 25549795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases 2, 7, 9 and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors.
    Kushlinsky NE; Solovyov YN; Babkina IV; Gershtein ES; Bulicheva IV
    Bull Exp Biol Med; 2010 Aug; 149(2):233-5. PubMed ID: 21113498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases 2, 7, and 9 and tissue inhibitor of metalloproteinases-1 in tumors and serum of patients with ovarian neoplasms.
    Gershtein ES; Levkina NV; Digayeva MA; Laktionov KP; Tereshkina IV; Kushlinsky NE
    Bull Exp Biol Med; 2010 Oct; 149(5):628-31. PubMed ID: 21165404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
    Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.